Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis
Allergy2014Vol. 69(7), pp. 954–959
Citations Over TimeTop 10% of 2014 papers
M. Reitter, Nadine Petitpain, Clotilde Latarche, J. Cottin, Nathalie Massy, Pascal Demoly, Pierre Gillet, Paul‐Michel Mertès
Abstract
Obese males with a history of cardiovascular disease receiving ongoing beta-blocker treatment and undergoing surgery in an emergency setting were at high risk of a fatal outcome after NMBA-induced anaphylaxis. Some epinephrine-resistant cases may play a role in our high mortality rate. New therapeutic approaches need to be developed to treat these cases.
Related Papers
- → Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring(2010)107 cited
- → Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital(2018)33 cited
- Pharmacovigilance an Overview(2011)
- → PHP187 Pharmacovigilance and the Case Study of VIOXX(2012)
- → A Questionnaire-Based Study to Evaluate the Basic Understanding of Pharmacovigilance of the Under Graduate Medical Students of a Rural Teaching Hospital(2021)